Fibroblastic niches in action: CCL19 + reticular cells drive anti-tumor immunity in lung cancer
Saved in:
| Main Authors: | Alessandro Ianni, Alejandro Vaquero, Thomas Braun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-03-01
|
| Series: | Signal Transduction and Targeted Therapy |
| Online Access: | https://doi.org/10.1038/s41392-025-02185-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fibroblastic reticular cell tumor of eyelid: Rare case report and review of literature
by: Pragnya P. Mishra, et al.
Published: (2023-01-01) -
Functional organotypic human lymph node model with native immune cells benefits from fibroblastic reticular cell enrichment
by: Andrew I. Morrison, et al.
Published: (2025-04-01) -
Myeloid‐Derived Suppressor Cell Accumulation Drives Intestinal Fibrosis through mCCL6/hCCL15 Chemokine‐Mediated Fibroblast Activation
by: Xiaohui Cheng, et al.
Published: (2025-02-01) -
The SIRT7-nucleolus connection in cancer: ARF enters the fray
by: Shahriar Tarighi, et al.
Published: (2024-12-01) -
The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer
by: Marjorie De la Fuente López, et al.
Published: (2018-11-01)